Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Peapack, New Jersey 07977


Purpose:

The purpose of this study is to see if it is safe and effective to give delavirdine mesylate (Rescriptor) plus two nucleoside reverse transcriptase inhibitors (NRTIs) to HIV-infected children and babies. This study also examines how the body processes Rescriptor when taken with 2 NRTIs.


Criteria:

Inclusion Criteria Patients must have: - HIV infection. - Plasma HIV-1 levels greater than 10,000 copies/ml.


NCT ID:

NCT00002210


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Peapack, New Jersey 07977
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.